36 participants
A Study of Ibrutinib With Rituximab in Relapsed or Refractory Mantle Cell Lymphoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2025-10-07
- Start Date:
- 2022-12-06
- Completion:
- 2023-12-06
Conditions
- Lymphoma, Mantle-Cell
Interventions
- DRUG